🇺🇸 Mifepristone + Misoprostol in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Abortion Induced — 1 report (10%)
2. Asthenia — 1 report (10%)
3. Cardio-Respiratory Arrest — 1 report (10%)
4. Chest Pain — 1 report (10%)
5. Coronary Artery Disease — 1 report (10%)
6. Delirium — 1 report (10%)
7. Diarrhoea — 1 report (10%)
8. Feeling Abnormal — 1 report (10%)
9. Hyperhidrosis — 1 report (10%)
10. Malaise — 1 report (10%)

Source database →

Frequently asked questions

Is Mifepristone + Misoprostol approved in United States?

Mifepristone + Misoprostol does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Mifepristone + Misoprostol in United States?

Gynuity Health Projects is the originator. The local marketing authorisation holder may differ — check the official source linked above.